PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01

Reported: April 8, 2020 Initiated: April 1, 2020 #D-1079-2020

Product Description

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01

Reason for Recall

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

Details

Units Affected
25,944 bottles
Distribution
U.S.A. Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 25,944 bottles.
Why was this product recalled?
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 8, 2020. Severity: Moderate. Recall number: D-1079-2020.